Intelgenx technologies corporation

0.00 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Intelgenx technologies corporation stock is down -100% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 17 May’s closed higher than April.

About Intelgenx technologies corporation

IntelGenx Technologies Corp. focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use. INT0043/2015, an oral film containing montelukast for treatment of Alzheimer, and INT0027/2011 to treat opioid addition. The company has licensing, development, and supply agreement with Tilray, Inc. and Cynapsus Therapeutics Inc.